Literature DB >> 15807864

Alpha tropomyosin as a self-antigen in patients with Behçet's disease.

S P Mahesh1, Zhuqing Li, R Buggage, F Mor, I R Cohen, E Y Chew, R B Nussenblatt.   

Abstract

We report for the first time a significant increased lymphoproliferative response to alpha tropomyosin as well as observing autoantibodies to tropomyosin observed in Behcet's disease (BD) patients with posterior uveitis. Peripheral blood mononuclear cells (PBMCs) from 18 BD patients with posterior uveitis, 18 patients with other forms of noninfectious uveitis, 9 patients with retinal damage due to photocoagulation as well as 18 healthy donors were evaluated for antigen-specific lymphoproliferative responses to alpha tropomyosin and its derivative peptides. The proliferative responses of PBMCs to these antigens were studied using (3)H thymidine incorporation assay. Serum samples were also screened by ELISA for autoantibodies against tropomyosin. Six of the 18 (33%) BD patients with posterior uveitis showed increased proliferative response to alpha tropomyosin or its derivative peptides, while none of the healthy, disease controls were positive. The mean lymphoproliferative responses to tropomyosin were significantly higher (P < 0.02) in the BD patients compared to healthy or disease controls. Higher titres of anti-tropomyosin antibodies were also seen in four of the 18 BD patients but none in the healthy or disease control groups (P < 0.002). The occurrence of these abnormalities supports a possible role for alpha tropomyosin as a self-antigen in a subset of patients with Behcet's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15807864      PMCID: PMC1809367          DOI: 10.1111/j.1365-2249.2005.02760.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Behçet's disease.

Authors:  T Sakane; M Takeno; N Suzuki; G Inaba
Journal:  N Engl J Med       Date:  1999-10-21       Impact factor: 91.245

2.  Anticardiolipin antibodies in Behçet's disease: a reassessment.

Authors:  S Tokay; H Direskeneli; S Yurdakul; T Akoglu
Journal:  Rheumatology (Oxford)       Date:  2001-02       Impact factor: 7.580

3.  Behçet's syndrome.

Authors:  M R Stanford
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

4.  Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome.

Authors:  Felix Mor; Abraham Weinberger; Irun R Cohen
Journal:  Eur J Immunol       Date:  2002-02       Impact factor: 5.532

5.  T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease.

Authors:  H Direskeneli; E Ekşioglu-Demiralp; S Yavuz; T Ergun; T Shinnick; T Lehner; T Akoglu
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

6.  Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases.

Authors:  T Matsui; M Kurokawa; T Kobata; S Oki; M Azuma; S Tohma; T Inoue; K Yamamoto; K Nishioka; T Kato
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

7.  Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls.

Authors:  M D de Smet; M Dayan
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

8.  Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.

Authors:  R B Nussenblatt; E Fortin; R Schiffman; L Rizzo; J Smith; P Van Veldhuisen; P Sran; A Yaffe; C K Goldman; T A Waldmann; S M Whitcup
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

9.  Species-dependent immunological differences between various mammalian cardiac tropomyosins.

Authors:  J Leger; P Bouveret; A M Lompre; K Schwartz
Journal:  Biochim Biophys Acta       Date:  1979-02-26

10.  IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.

Authors:  John F McDyer; Zhuqing Li; Susan John; Xiang Yu; Chang-You Wu; Jack A Ragheb
Journal:  J Immunol       Date:  2002-09-01       Impact factor: 5.422

View more
  10 in total

1.  Past and Present Behçet's Disease Animal Models.

Authors:  Jermilia Charles; Francis J Castellino; Victoria A Ploplis
Journal:  Curr Drug Targets       Date:  2020       Impact factor: 3.465

Review 2.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

3.  Propolis modulates NOS2/arginase-1 pathway in tropomyosin-induced experimental autoimmune uveitis.

Authors:  Kahina Touri; Houda Belguendouz; Oussama Medjeber; Zineb Djeraba; Karima Lahmar; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-05-11       Impact factor: 4.473

4.  Pro-inflammatory cellular immune response in Behçet's disease.

Authors:  Ayla Kulaber; Ilknur Tugal-Tutkun; Sibel P Yentür; Gülşen Akman-Demir; Fumio Kaneko; Ahmet Gül; Güher Saruhan-Direskeneli
Journal:  Rheumatol Int       Date:  2007-06-05       Impact factor: 2.631

Review 5.  Molecular mimicry as a mechanism of autoimmune disease.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

6.  Identification of kinectin as a novel Behçet's disease autoantigen.

Authors:  Yu Lu; Ping Ye; Shun-le Chen; Eng M Tan; Edward K L Chan
Journal:  Arthritis Res Ther       Date:  2005-07-27       Impact factor: 5.156

Review 7.  Immunopathogenesis of Behcet's Disease.

Authors:  Bainan Tong; Xiaoli Liu; Jun Xiao; Guanfang Su
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

8.  Lymphocyte proliferation induced by high-affinity peptides for HLA-B*51:01 in Behçet's uveitis.

Authors:  Toshikatsu Kaburaki; Hisae Nakahara; Rie Tanaka; Kimiko Okinaga; Hidetoshi Kawashima; Youichiro Hamasaki; Thanyada Rungrotmongkol; Supot Hannongbua; Hiroshi Noguchi; Makoto Aihara; Fujio Takeuchi
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

9.  Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab.

Authors:  Xavier M Teitsma; Jenny Devenport; Johannes W G Jacobs; Attila Pethö-Schramm; Michelle E A Borm; Petra Budde; Johannes W J Bijlsma; Floris P J G Lafeber
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

10.  Comparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone Acetonide.

Authors:  Zeljka Smit-McBride; Elad Moisseiev; Sara P Modjtahedi; David G Telander; Leonard M Hjelmeland; Lawrence S Morse
Journal:  J Ophthalmol       Date:  2016-06-27       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.